{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:25:16Z","timestamp":1782170716031,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tampere University graduate school"},{"DOI":"10.13039\/501100008413","name":"Instrumentarium Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Research Foundation of the Pulmonary Diseases"},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Allergy research foundation"},{"name":"The Jane and Aatos Erkko Foundation"},{"name":"The Sigrid Juselius Foundation"},{"name":"The Research Council of Finland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94656-0","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:38:37Z","timestamp":1742881117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunological and structural evaluation of the intranasally administrated CVB1 whole-virus and VLP vaccines"],"prefix":"10.1038","volume":"15","author":[{"given":"Saana","family":"Soppela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatka","family":"Plavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Gr\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iiris","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minne","family":"Jartti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Oikarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Laajala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varpu","family":"Marjom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna M.","family":"Hankaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"94656_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jmv.21998","volume":"83","author":"AH Wong","year":"2011","unstructured":"Wong, A. H., Lau, C. S., Cheng, P. K., Ng, A. Y. & Lim, W. W. Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong. J. Med. Virol. 83, 483\u2013489 (2011).","journal-title":"J. Med. Virol."},{"key":"94656_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1089\/vim.2004.17.358","volume":"17","author":"S Huber","year":"2004","unstructured":"Huber, S. & Ramsingh, A. I. Coxsackievirus-induced pancreatitis. Viral Immunol. 17, 358\u2013369 (2004).","journal-title":"Viral Immunol."},{"key":"94656_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.326","volume":"11","author":"KS Kim","year":"2001","unstructured":"Kim, K. S., Hufnagel, G., Chapman, N. M. & Tracy, S. The group B coxsackieviruses and myocarditis. Rev. Med. Virol. 11, 355\u2013368 (2001).","journal-title":"Rev. Med. Virol."},{"key":"94656_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/317145a0","volume":"317","author":"MG Rossmann","year":"1985","unstructured":"Rossmann, M. G. et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145\u2013153 (1985).","journal-title":"Nature"},{"key":"94656_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.chom.2021.01.001","volume":"29","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating. Cell. Host Microbe. 29, 448\u2013462e5 (2021).","journal-title":"Cell. Host Microbe"},{"key":"94656_CR6","doi-asserted-by":"crossref","unstructured":"Richardson, J. S. The anatomy and taxonomy of protein structure. in Advances in Protein Chemistry (eds Anfinsen, C. B., Edsall, J. T. & Richards, F. M.) vol. 34 167\u2013339 (Academic, (1981).","DOI":"10.1016\/S0065-3233(08)60520-3"},{"key":"94656_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/pro.5560031005","volume":"3","author":"R Basavappa","year":"1994","unstructured":"Basavappa, R. et al. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 3, 1651\u20131669 (1994).","journal-title":"Protein Sci."},{"key":"94656_CR8","doi-asserted-by":"publisher","first-page":"e0136722","DOI":"10.1128\/jvi.01367-22","volume":"96","author":"A Domanska","year":"2022","unstructured":"Domanska, A. et al. Structural studies reveal that endosomal cations promote formation of infectious coxsackievirus A9 A-Particles, facilitating RNA and VP4 release. J. Virol. 96, e0136722 (2022).","journal-title":"J. Virol."},{"key":"94656_CR9","doi-asserted-by":"publisher","first-page":"e1700324","DOI":"10.1002\/biot.201700324","volume":"13","author":"X Ding","year":"2018","unstructured":"Ding, X., Liu, D., Booth, G., Gao, W. & Lu, Y. Virus-Like particle engineering: from rational design to versatile applications. Biotechnol. J. 13, e1700324 (2018).","journal-title":"Biotechnol. J."},{"key":"94656_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/bit.25159","volume":"111","author":"LH Lua","year":"2014","unstructured":"Lua, L. H. et al. Bioengineering virus-like particles as vaccines. Biotechnol. Bioeng. 111, 425\u2013440 (2014).","journal-title":"Biotechnol. Bioeng."},{"key":"94656_CR11","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1016\/j.vaccine.2017.05.057","volume":"35","author":"MM Hankaniemi","year":"2017","unstructured":"Hankaniemi, M. M. et al. Optimized production and purification of coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. Vaccine 35, 3718\u20133725 (2017).","journal-title":"Vaccine"},{"key":"94656_CR12","doi-asserted-by":"publisher","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","volume":"6","author":"VM Stone","year":"2020","unstructured":"Stone, V. M. et al. A hexavalent coxsackievirus B vaccine is highly Immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci. Adv. 6, eaaz2433 (2020).","journal-title":"Sci. Adv."},{"key":"94656_CR13","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1016\/j.vaccine.2019.08.037","volume":"37","author":"MM Hankaniemi","year":"2019","unstructured":"Hankaniemi, M. M. et al. A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a coxsackievirus B1 vaccine. Vaccine 37, 5962\u20135971 (2019).","journal-title":"Vaccine"},{"key":"94656_CR14","doi-asserted-by":"publisher","first-page":"104595","DOI":"10.1016\/j.antiviral.2019.104595","volume":"171","author":"MM Hankaniemi","year":"2019","unstructured":"Hankaniemi, M. M. et al. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine. Antiviral Res. 171, 104595 (2019).","journal-title":"Antiviral Res."},{"key":"94656_CR15","doi-asserted-by":"publisher","unstructured":"Hankaniemi, M. M. et al. Structural insight into CVB3-VLP Non-Adjuvanted vaccine. Microorganisms 8 https:\/\/doi.org\/10.3390\/microorganisms8091287 (2020).","DOI":"10.3390\/microorganisms8091287"},{"key":"94656_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/hep.24610","volume":"54","author":"S Ciesek","year":"2011","unstructured":"Ciesek, S. et al. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 54, 1947\u20131955 (2011).","journal-title":"Hepatology"},{"key":"94656_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/hep.24803","volume":"55","author":"N Calland","year":"2012","unstructured":"Calland, N. et al. -)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55, 720\u2013729 (2012).","journal-title":"Hepatology"},{"key":"94656_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3748\/wjg.v17.i11.1507","volume":"17","author":"W He","year":"2011","unstructured":"He, W., Li, L. X., Liao, Q. J., Liu, C. L. & Chen, X. L. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line. World J. Gastroenterol. 17, 1507\u20131514 (2011).","journal-title":"World J. Gastroenterol."},{"key":"94656_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1348-0421.2002.tb02724.x","volume":"46","author":"N Imanishi","year":"2002","unstructured":"Imanishi, N. et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol. Immunol. 46, 491\u2013494 (2002).","journal-title":"Microbiol. Immunol."},{"key":"94656_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/acm.2006.12.669","volume":"12","author":"H Yamada","year":"2006","unstructured":"Yamada, H., Takuma, N., Daimon, T. & Hara, Y. Gargling with tea Catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study. J. Altern. Complement. Med. 12, 669\u2013672 (2006).","journal-title":"J. Altern. Complement. Med."},{"key":"94656_CR21","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1021\/jf901128u","volume":"57","author":"HY Ho","year":"2009","unstructured":"Ho, H. Y., Cheng, M. L., Weng, S. F., Leu, Y. L. & Chiu, D. T.-Y. Antiviral effect of Epigallocatechin gallate on enterovirus 71. J. Agric. Food Chem. 57, 6140\u20136147 (2009).","journal-title":"J. Agric. Food Chem."},{"key":"94656_CR22","doi-asserted-by":"crossref","unstructured":"Cheong, Y. et al. Epigallocatechin-3-Gallate as a novel vaccine adjuvant. Front. Immunol. 12, (2021).","DOI":"10.3389\/fimmu.2021.769088"},{"key":"94656_CR23","first-page":"1182","volume":"13","author":"D Reshamwala","year":"2021","unstructured":"Reshamwala, D. et al. Polyphenols Epigallocatechin gallate and Resveratrol, and Polyphenol-Functionalized nanoparticles prevent enterovirus infection through clustering and stabilization of the viruses. Pharm. 2021. 13, 1182 (2021).","journal-title":"Pharm. 2021"},{"key":"94656_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1586\/14760584.6.2.133","volume":"6","author":"M Kundi","year":"2007","unstructured":"Kundi, M. New hepatitis B vaccine formulated with an improved adjuvant system. Expert Rev. Vaccines. 6, 133\u2013140 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"94656_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","volume":"61","author":"VM Stone","year":"2018","unstructured":"Stone, V. M. et al. A coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia 61, 476\u2013481 (2018).","journal-title":"Diabetologia"},{"key":"94656_CR26","doi-asserted-by":"publisher","unstructured":"Stone, V. M. et al. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect. Diabetes db210193 (2021). https:\/\/doi.org\/10.2337\/db21-0193","DOI":"10.2337\/db21-0193"},{"key":"94656_CR27","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.4049\/jimmunol.180.9.6159","volume":"180","author":"K Yang","year":"2008","unstructured":"Yang, K. et al. A DNA vaccine prime followed by a Liposome-Encapsulated protein boost confers enhanced mucosal immune responses and Protection1. J. Immunol. 180, 6159\u20136167 (2008).","journal-title":"J. Immunol."},{"key":"94656_CR28","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1128\/JVI.01809-14","volume":"88","author":"T Wilton","year":"2014","unstructured":"Wilton, T., Dunn, G., Eastwood, D., Minor, P. D. & Martin, J. Effect of formaldehyde inactivation on poliovirus. J. Virol. 88, 11955\u201311964 (2014).","journal-title":"J. Virol."},{"key":"94656_CR29","doi-asserted-by":"publisher","first-page":"e3000281","DOI":"10.1371\/journal.pbio.3000281","volume":"17","author":"R Abdelnabi","year":"2019","unstructured":"Abdelnabi, R. et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 17, e3000281 (2019).","journal-title":"PLoS Biol."},{"key":"94656_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-01779-x","volume":"4","author":"JW Flatt","year":"2021","unstructured":"Flatt, J. W., Domanska, A., Sepp\u00e4l\u00e4, A. L. & Butcher, S. J. Identification of a conserved virion-stabilizing network inside the interprotomer pocket of enteroviruses. Commun. Biol. 4, 1\u20138 (2021).","journal-title":"Commun. Biol."},{"key":"94656_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"94656_CR32","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","volume":"32","author":"Z Ku","year":"2014","unstructured":"Ku, Z. et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 32, 4296\u20134303 (2014).","journal-title":"Vaccine"},{"key":"94656_CR33","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s11033-020-05333-6","volume":"47","author":"IH Hassine","year":"2020","unstructured":"Hassine, I. H. et al. Characterization of coxsackievirus B4 virus-like particles VLP produced by the Recombinant baculovirus-insect cell system expressing the major capsid protein. Mol. Biol. Rep. 47, 2835\u20132843 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"94656_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.vaccine.2017.12.057","volume":"36","author":"W Dai","year":"2018","unstructured":"Dai, W. et al. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine 36, 653\u2013659 (2018).","journal-title":"Vaccine"},{"key":"94656_CR35","first-page":"91","volume":"7","author":"W Zhang","year":"2018","unstructured":"Zhang, W. et al. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerg. Microbes Infections. 7, 91\u201394 (2018).","journal-title":"Emerg. Microbes Infections"},{"key":"94656_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0166-3542(93)90008-7","volume":"21","author":"M Nakayama","year":"1993","unstructured":"Nakayama, M. et al. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 21, 289\u2013299 (1993).","journal-title":"Antiviral Res."},{"key":"94656_CR37","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00705-019-04418-3","volume":"164","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice. Arch. Virol. 164, 2975\u20132984 (2019).","journal-title":"Arch. Virol."},{"key":"94656_CR38","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1038\/s41598-018-28281-5","volume":"8","author":"YL Lin","year":"2018","unstructured":"Lin, Y. L. et al. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge. Sci. Rep. 8, 10713 (2018).","journal-title":"Sci. Rep."},{"key":"94656_CR39","doi-asserted-by":"publisher","first-page":"e0246422","DOI":"10.1371\/journal.pone.0246422","volume":"16","author":"R Tada","year":"2021","unstructured":"Tada, R. et al. Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice. PLOS ONE. 16, e0246422 (2021).","journal-title":"PLOS ONE"},{"key":"94656_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imm.12614","volume":"148","author":"S Patel","year":"2016","unstructured":"Patel, S. et al. Vitamin A or E and a Catechin synergize as vaccine adjuvant to enhance immune responses in mice by induction of early interleukin-15 but not interleukin\u20101\u03b2 responses. Immunology 148, 352\u2013362 (2016).","journal-title":"Immunology"},{"key":"94656_CR41","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.chom.2022.08.001","volume":"30","author":"Q Zheng","year":"2022","unstructured":"Zheng, Q. et al. Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail. Cell. Host Microbe. 30, 1279\u20131294e6 (2022).","journal-title":"Cell. Host Microbe"},{"key":"94656_CR42","doi-asserted-by":"publisher","unstructured":"Kingston, N. et al. (ed, J.) Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidate. The Journal of general virology. 104(6), 001867 https:\/\/doi.org\/10.1099\/jgv.0.001867 (2023).","DOI":"10.1099\/jgv.0.001867"},{"key":"94656_CR43","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.sbi.2024.102913","volume":"88","author":"T Shimizu","year":"2024","unstructured":"Shimizu, T. RNA recognition in toll-like receptor signaling. Curr. Opin. Struct. Biol. 88, 102913 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"94656_CR44","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/jmv.23903","volume":"86","author":"S H\u00e4m\u00e4l\u00e4inen","year":"2014","unstructured":"H\u00e4m\u00e4l\u00e4inen, S. et al. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity. J. Med. Virol. 86, 1412\u20131420 (2014).","journal-title":"J. Med. Virol."},{"key":"94656_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","volume":"36","author":"C Lei","year":"2020","unstructured":"Lei, C., Yang, J., Hu, J. & Sun, X. On the calculation of TCID50 for quantitation of virus infectivity. Virol. Sin. 36, 141\u2013144 (2020).","journal-title":"Virol. Sin"},{"key":"94656_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"94656_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsb.2016.04.010","volume":"195","author":"JM de la Rosa-Trev\u00edn","year":"2016","unstructured":"de la Rosa-Trev\u00edn, J. M. et al. Scipion: A software framework toward integration, reproducibility and validation in 3D electron microscopy. J. Struct. Biol. 195, 93\u201399 (2016).","journal-title":"J. Struct. Biol."},{"key":"94656_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. & RELION Implementation of a bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"94656_CR49","doi-asserted-by":"crossref","unstructured":"Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife 5, e18722 (2016).","DOI":"10.7554\/eLife.18722"},{"key":"94656_CR50","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"94656_CR51","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"94656_CR52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jmb.2011.11.010","volume":"415","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. A bayesian view on Cryo-EM structure determination. J. Mol. Biol. 415, 406\u2013418 (2012).","journal-title":"J. Mol. Biol."},{"key":"94656_CR53","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods. 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"94656_CR54","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jmb.2003.07.013","volume":"333","author":"PB Rosenthal","year":"2003","unstructured":"Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721\u2013745 (2003).","journal-title":"J. Mol. Biol."},{"key":"94656_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"94656_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF chimerax: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"94656_CR57","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"94656_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"94656_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"94656_CR60","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2144\/btn-2021-0022","volume":"71","author":"B Luckow","year":"2021","unstructured":"Luckow, B. & Lehmann, M. H. A simplified method for Bronchoalveolar lavage in mice by orotracheal intubation avoiding tracheotomy. Biotechniques 71, 534\u2013537 (2021).","journal-title":"Biotechniques"},{"key":"94656_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jat.727","volume":"21","author":"KH Diehl","year":"2001","unstructured":"Diehl, K. H. et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21, 15\u201323 (2001).","journal-title":"J. Appl. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94656-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94656-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94656-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T13:55:59Z","timestamp":1743083759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94656-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94656-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments in this study were carried out following the Finnish Act on the Protection of Animals Used for Scientific or Educational Purposes (497\/2013). Procedures were approved by the Regional State Administrative Agency, Pirkanmaa, Finland (decision number ESAVI\/1408\/2021). All animal reporting was conducted in accordance with ARRIVE guidelines. All efforts were made to minimize animal suffering and to reduce the number of animals used. The welfare of the animals was monitored throughout the experiment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"10198"}}